A high-throughput drug sensitivity testing platform utilizing renewable primary cancer cells to predict treatment response. This service enables personalized treatment selection through comprehensive chemotherapy and targeted drug profiling.
Manufactured by
China
PreceDo Pharmaceuticals is a state-controlled high-tech enterprise established in 2015, affiliated with Chinese Academy of Sciences Hefei Institute. The company specializes in cell engineering technology, featuring proprietary HDS tumor precision medication technology, Ba/F3 cancer kinase target engineered cell library, and an approved renewable cancer primary cell biobank for anti-tumor drug development and clinical precision treatment.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Jiangsu Avatarget Biotechnology Limited Liability Company
China · 1 relevant product
Yashraj Biotechnology GmbH
Germany · 1 relevant product
BioChain (Beijing) Science & Technology. Inc.
China · 2 relevant products
43 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →11 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 68 closest product alternatives
Jiangsu Avatarget Biotechnology Limited Liability Company · China
Clinical service for personalized cancer drug response evaluation using patient-derived tumor organoids and organ chips. Supports precision medicine treatment selection and optimization.
Yashraj Biotechnology GmbH · Germany
Comprehensive service for discovering and identifying new cancer biomarkers in human serum and plasma samples to advance precision medicine and diagnostics.
BioChain (Beijing) Science & Technology. Inc. · China
A targeted blood-based early detection service for specific cancer types utilizing gene methylation biomarkers. This clinical testing service is performed by BioChain's certified medical laboratory.
65 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products